TrialJournal of infection and public health2022

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients.

Rania M Sarhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.